bis(1,3-diethylthiobarbiturate)trimethineoxonol has been researched along with veratridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, T; Kitayama, S; Morita, K; Ohtsuki, H; Tsujimoto, A | 1 |
| Amoroso, S; Annunziato, L; Di Renzo, G; Iannotti, E; Saggese, ML | 1 |
2 other study(ies) available for bis(1,3-diethylthiobarbiturate)trimethineoxonol and veratridine
| Article | Year |
|---|---|
Bis-oxonol experiment on plasma membrane potentials of bovine adrenal chromaffin cells: depolarizing stimuli and their possible interaction.
Topics: Acetylcholine; Adrenal Glands; Animals; Cattle; Cell Membrane; Chromaffin System; Fluorescent Dyes; gamma-Aminobutyric Acid; Membrane Potentials; Thiobarbiturates; Veratridine | 1990 |
The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings.
Topics: Adenosine; Animals; Cerebral Cortex; Fluorescent Dyes; Male; Membrane Potentials; Nerve Endings; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Synaptosomes; Thiobarbiturates; Triazoles; Veratridine; Xanthines | 1995 |